Figures S1-S2 from Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases Por Sheheryar Kabraji (15050565)

Assuntos:

Table S7 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Supplementary Table S3 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TN... Por Holly Tovey (16824233)

Assuntos:

Table S1 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Table S8 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Table S3 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

File_S1 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Table S2 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Table S4 from CD25^high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer Por Stéphane Fattori (15048281)

Assuntos:

Overview of themes and subthemes for determinants affecting the process of favorable lifestyle change. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Overview of the patient journey of PMBC survivors, including the most common healthcare professionals involved at each stage. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Visualization of the focus of the interviews at 1 and 1.5 years following diagnosis. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Overview of themes and subthemes and association with preferred timing for lifestyle support by PMBC survivors. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Socio-demographic and clinical characteristics. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Postmenopausal breast cancer survivors’ needs regarding lifestyle support by health care professionals. Por Sandra J. M. van Cappellen – van Maldegem (22676378)

Assuntos:

Table S1 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... Por Xiaoqing Cheng (16918496)

Assuntos:

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary... Por Noor Jailkhani (16015810)

Assuntos:

Table S5 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... Por Xiaoqing Cheng (16918496)

Assuntos:

Table S6 from Breast Cancer Mutations <i>HER2^V777L</i> and <i>PIK3CA^H1047R</i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistan... Por Xiaoqing Cheng (16918496)

Assuntos:

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary... Por Noor Jailkhani (16015810)

Assuntos: